Collectively, these data illustrated that overexpression of SELENBP1 significantly restrained the proliferation, migration, and invasion of NSCLC cells at least in part through inactivating the PI3K/AKT/mTOR signaling pathway in vitro. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.